Hepatitis B virus-infected HepG2hNTCP cells serve as a novel immunological tool to analyze the antiviral efficacy of CD8+ T cells in vitro

CD8+ T cells are the main effector lymphocytes in the control of hepatitis B virus (HBV) infection. However, limitations of model systems, such as low infection rates, restrict mechanistic studies of HBV-specific CD8+ T cells. Here, we established a novel immunological cell culture model based on HB...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hoh, Alexander (VerfasserIn) , Urban, Stephan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 15 July 2015
In: Journal of virology
Year: 2015, Jahrgang: 89, Heft: 14, Pages: 7433-7438
ISSN:1098-5514
DOI:10.1128/JVI.00605-15
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1128/JVI.00605-15
Verlag, kostenfrei, Volltext: https://journals.asm.org/doi/10.1128/jvi.00605-15
Volltext
Verfasserangaben:Alexander Hoh, Maximilian Heeg, Yi Ni, Anita Schuch, Benedikt Binder, Nadine Hennecke, Hubert E. Blum, Michael Nassal, Ulrike Protzer, Maike Hofmann, Stephan Urban, Robert Thimme
Beschreibung
Zusammenfassung:CD8+ T cells are the main effector lymphocytes in the control of hepatitis B virus (HBV) infection. However, limitations of model systems, such as low infection rates, restrict mechanistic studies of HBV-specific CD8+ T cells. Here, we established a novel immunological cell culture model based on HBV-infected HepG2hNTCP cells that endogenously processed viral antigens and presented them to HBV-specific CD8+ T cells. This induced cytolytic and noncytolytic CD8+ T-cell effector functions and reduction of viral loads.
Beschreibung:Im Titel ist „hNTCP“ und "+"hochgestellt
Gesehen am 04.04.2017
Beschreibung:Online Resource
ISSN:1098-5514
DOI:10.1128/JVI.00605-15